Sestrin2 modulates AMPK subunit expression and its response to ionizing radiation in breast cancer cells

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Sanli, Toran ^a   Linher Melville, Katja ^a   Tsakiridis, Theodoros ^a   Singh, Gurmit ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE BETA1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE GAMMA1; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE LKB1; TETRACYCLINE; THREONINE 127 PROTEINASE; THREONINE PROTEINASE; UNCLASSIFIED DRUG; NUCLEAR PROTEIN; SESN2 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL STRAIN; CELL STRAIN MCF7; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME MECHANISM; GENE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IONIZING RADIATION; MODULATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; SESN2 GENE; SIGNAL TRANSDUCTION; UPREGULATION; BIOLOGICAL MODEL; BREAST TUMOR; CELL FRACTIONATION; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; ENZYMOLOGY; FEMALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN SUBUNIT; RADIATION EXPOSURE; TUMOR CELL LINE;

AMP-ACTIVATED PROTEIN KINASES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; FEMALE; HUMANS; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN SUBUNITS; RADIATION, IONIZING; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

EID: 84857412162     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032035     Document Type: Article

References (35)

1. Benz CC, Yau C, (2008) Ageing, oxidative stress and cancer: paradigms in parallax. Nat Rev Cancer 8: 875-879.
2. Budanov AV, Lee JH, Karin M, (2010) Stressin' Sestrins take an aging fight. EMBO Mol Med 2: 388-400.
3. Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, et al. (2007) The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res 67: 3043-3053.
4. Budanov AV, Karin M, (2008) p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134: 451-460.
5. Budanov AV, Sablina AA, Feinstein E, Koonin EV, Chumakov PM, (2004) Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304: 596-600.
6. Lee JH, Budanov AV, Park EJ, Birse R, Kim TE, et al. (2010) Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies. Science 327: 1223-1228.
7. Velasco-Miguel S, Buckbinder L, Jean P, Gelbert L, Talbott R, et al. (1999) PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes. Oncogene 18: 127-137.
8. Budanov AV, Shoshani T, Faerman A, Zelin E, Kamer I, et al. (2002) Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. Oncogene 21: 6017-6031.
9. Chen CC, Jeon SM, Bhaskar PT, Nogueira V, Sundararajan D, et al. (2010) FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor. Dev Cell 18: 592-604.
10. Peeters H, Debeer P, Bairoch A, Wilquet V, Huysmans C, et al. (2003) PA26 is a candidate gene for heterotaxia in humans: identification of a novel PA26-related gene family in human and mouse. Hum Genet 112: 573-580.
11. Budanov AV, (2010) Stress-responsive Sestrins link p53 with redox regulation and mTOR signaling. Antioxid Redox Signal.
12. Maiuri MC, Malik SA, Morselli E, Kepp O, Criollo A, et al. (2009) Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle 8: 1571-1576.
13. Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, et al. (2005) The antioxidant function of the p53 tumor suppressor. Nat Med 11: 1306-1313.
14. Steinberg GR, Kemp BE, (2009) AMPK in Health and Disease. Physiol Rev 89: 1025-1078.
15. Fogarty S, Hardie DG, (2009) Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim Biophys Acta 1804: 581-591.
16. Iseli TJ, Oakhill JS, Bailey MF, Wee S, Walter M, et al. (2008) AMP-activated protein kinase subunit interactions: beta1:gamma1 association requires beta1 Thr-263 and Tyr-267. J Biol Chem 283: 4799-4807.
17. Viollet B, Athea Y, Mounier R, Guigas B, Zarrinpashneh E, et al. (2009) AMPK: Lessons from transgenic and knockout animals. Front Biosci 14: 19-44.
18. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, et al. (2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18: 283-293.
19. Hardie DG, (2008) AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond) 32 (Suppl 4): S7-12.
20. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, et al. (1998) A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391: 184-187.
21. Sanli T, Rashid A, Liu C, Harding S, Bristow RG, et al. (2010) Ionizing Radiation Activates AMP-Activated Kinase (AMPK): A Target for Radiosensitization of Human Cancer Cells. Int J Radiat Oncol Biol Phys 78: 221-229.
22. Bristow RG, Hill RP, (2008) Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 8: 180-192.
23. Braunstein S, Badura ML, Xi Q, Formenti SC, Schneider RJ, (2009) Regulation of protein synthesis by ionizing radiation. Mol Cell Biol 29: 5645-5656.
24. Horman S, Vertommen D, Heath R, Neumann D, Mouton V, et al. (2006) Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491. J Biol Chem 281: 5335-5340.
25. Nogueira V, Park Y, Chen CC, Xu PZ, Chen ML, et al. (2008) Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14: 458-470.
26. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, et al. (2004) The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A 101: 3329-3335.
27. Woods A, Vertommen D, Neumann D, Turk R, Bayliss J, et al. (2003) Identification of phosphorylation sites in AMP-activated protein kinase (AMPK) for upstream AMPK kinases and study of their roles by site-directed mutagenesis. J Biol Chem 278: 28434-28442.
28. Kodiha M, Rassi JG, Brown CM, Stochaj U, (2007) Localization of AMP kinase is regulated by stress, cell density, and signaling through the MEK->ERK1/2 pathway. Am J Physiol Cell Physiol 293: C1427-1436.
29. Salt I, Celler JW, Hawley SA, Prescott A, Woods A, et al. (1998) AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. Biochem J 334 (Pt 1): 177-187.
30. Hay N, (2008) p53 strikes mTORC1 by employing sestrins. Cell Metab 8: 184-185.
31. Okoshi R, Ozaki T, Yamamoto H, Ando K, Koida N, et al. (2008) Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress. J Biol Chem 283: 3979-3987.
32. Wullschleger S, Loewith R, Hall MN, (2006) TOR signaling in growth and metabolism. Cell 124: 471-484.
33. Zannella VE, Cojocari D, Hilgendorf S, Vellanki RN, Chung S, et al. (2011) AMPK regulates metabolism and survival in response to ionizing radiation. Radiother Oncol.
34. Sanli T, Liu C, Rashid A, Hopmans SN, Tsiani E, et al. (2011) Lovastatin sensitizes lung cancer cells to ionizing radiation: modulation of molecular pathways of radioresistance and tumor suppression. J Thorac Oncol 6: 439-450.
35. Linher-Melville K, Zantinge S, Sanli T, Gerstein H, Tsakiridis T, et al. (2011) Establishing a relationship between prolactin and altered fatty acid beta-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells. BMC Cancer 11: 56.